MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock,...
$25,765K
Proceeds from exercise of
warrants
$1,527K
Net cash provided by
financing activities
$27,284K
Effect of exchange rate
changes on cash and cash...
$51K
Canceled cashflow
$8K
Net increase
(decrease) in cash and cash...
$4,600K
Canceled cashflow
$22,735K
Payment of tax liability
for vested...
$8K
Loss on issuance of
warrant liabilities
-$30,962K
Stock-based compensation
$1,664K
Transaction costs allocated
to warrant...
$1,407K
Accounts payable
$1,330K
Loss on
extinguishment of warrant...
-$614K
Depreciation and
amortization
$90K
Accrued expenses and
other liabilities
$17K
Net cash used in
operating activities
-$22,735K
Canceled cashflow
$36,084K
Net loss
-$33,560K
Change in fair value of
warrant liabilities
-$24,441K
Prepaid expenses and
other assets
$792K
Operating lease, net
-$26K
Back
Back
Cash Flow
source: myfinsight.com
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)